Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Neurologic and Psychiatric Adverse Events of Several Antiretroviral Drugs in Real Life Setting

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* HIV infection~* age \> 18~* treatment with rilpivirine, elvitegravir, or dolutegravir (for exposed patients)~* treatment with none of these drugs (for non exposed patients)~* capacity of reading French language~Exclusion Criteria:~* drugs addiction (except for amyl nitriles (poppers) and cannabis)~* alcoholism~* co-infection with hepatitis C virus~* pregnant or breast feeding patient

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- exposition to the drugs (Type: None): patients treated with at least one of the following drugs: dolutegravir, elvitegravir and rilpivirine
- patients non exposed to the drugs (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).